In 2011, Stefanie Studenski presented her data on the powerful prediction of slow gait speed as an independent risk factor for mortality. This landmark paper raised the awareness of almost all disciplines in medicine and allied healthcare professionals to measure gait speed and develop a different perspective on physical mobility. This paper is also part…
One of the many impacts of the COVID-19 lockdown earlier this year, has been the severe restrictions on mobility of both patients and the public. Furthermore, the ability to assess patients’ mobility has suffered as well because of the barriers created between researchers and participants. Being able to remotely monitor patients’ mobility in their natural…
The Mobilise-D Consortium is incredibly proud that our own WP2 star academic leader, Professor Claudia Mazzà from the University of Sheffield, is a recipient of the Suffrage Science award, celebrating women in science for their scientific achievements and their ability to inspire others. The Suffrage Science scheme was founded by the Medical Research Council’s London Institute…
Mobility is often said to be a sixth vital sign, just as important as other vital signs such as blood pressure and heart rate, and the key to independence in our daily life. But what does mobility actually mean for people? And what happens when they experience mobility loss? We asked several people what the…
The gait of patients with Parkinson’s Disease is typically assessed in a laboratory but with current developments in sensor technology, their gait could be assessed in the home environment as well. But how comparable are these two? Researchers from University Hospital Erlangen studied this question. In a reliability analysis, they compared standardized and supervised sensor-based…
The Virtual Physiological Human Conference (VPH2020) was held online August 24-28 with several representatives from the Mobilise-D consortium. This year, the focus was on “When models, methods & experiments meet the clinic”. Prof. Claudia Mazzà from the University of Sheffield, Mobilise-D’s Academic Lead of WP2 – Algorithm development and technical validation, chaired the session “Monitoring &…
We are tremendously proud to announce that the Mobilise-D Technical Validation Study has officially started recruiting subjects! After the unprecedented times of COVID-19 lock-down that affected the entire world, we are now in a position to come back safely and restart our research in clinical settings. COVID-19 times are not over yet, and therefore we…
Walking limitations are debilitating symptoms in many chronic diseases, and are highly related to quality of life, fall risk, and economic burden. Unsurprisingly, walking ability is a common target of pharmacological or behavioural intervention. Thanks to advances in wearable sensor technologies, it is now possible to objectively monitor how, and how much, patients walk in…
The first year of Mobilise-D has passed and we can now look back at a year filled with hard work that all paid off in the end. Like the rest of the world, Mobilise-D faced some unexpected challenges the last few months (#COVID19). However, we have prevailed, and we will continue as planned with only…
The large-scale social and behavioural changes that happened almost overnight in our day-to-day life due to COVID-19, illustrate the importance of anticipating and developing new ways of patient care. Especially mobility is a telling sign of how well a patient is doing. “Mobility is something that we take for granted until we lose it. And…